In vitro safety and anti‐bacterial efficacy assessment of acriflavine

CONFLIC T OF INTERE S T Dr. Piontek, Dr. Ittermann, Dr. Arnold, Prof. Völzke and Prof. Baumeister have nothing to disclose. Prof. Apfelbacher reported consulting fees from Dr Wolff Group, Sanofi Genzyme, LEO Pharma; payment or honoraria for lectures, etc. from AstraZeneca; support for attending meetings and/or travel from Dr Wolff Group; and participation on a Data Safety Monitoring Board or Advisory Board in Dr Wolff Group. Prof. Apfelbacher is cochair of the Harmonising Outcome Measures for Eczema (HOME) initiative.

[1]  J. Gelfand,et al.  Burden of illness in adults with atopic dermatitis: Analysis of National Health and Wellness Survey data from France, Germany, Italy, Spain, and the United Kingdom. , 2019, Journal of the American Academy of Dermatology.

[2]  J. Silverberg.  Comorbidities and the impact of atopic dermatitis. , 2019, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[3]  J. Silverberg,et al.  Association between atopic dermatitis, depression, and suicidal ideation: A systematic review and meta-analysis. , 2019, Journal of the American Academy of Dermatology.

[4]  S. Chaturvedi,et al.  Somatization in the dermatology patient: Some sociocultural perspectives. , 2017, Clinics in dermatology.

[5]  Seung-Chul Lee.  Various diagnostic criteria for atopic dermatitis (AD): A proposal of Reliable Estimation of Atopic Dermatitis in Childhood (REACH) criteria, a novel questionnaire‐based diagnostic tool for AD , 2016, The Journal of dermatology.

[6]  W. Fokkens,et al.  International Consensus Statement on Allergy and Rhinology: Rhinosinusitis , 2016, International forum of allergy & rhinology.

[7]  Robert E W Hancock,et al.  Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies. , 2013, Current opinion in microbiology.

[8]  P. Wormald,et al.  The bacteriology of chronic rhinosinusitis and the pre‐eminence of Staphylococcus aureus in revision patients , 2013, International forum of allergy & rhinology.

[9]  U. Römling,et al.  Biofilm infections, their resilience to therapy and innovative treatment strategies , 2012, Journal of internal medicine.

[10]  A. Beule,et al.  Confocal Scanning Laser Microscopy Evidence of Biofilms in Patients With Chronic Rhinosinusitis , 2007, The Laryngoscope.

[11]  M. Gupta.  Somatization disorders in dermatology , 2006, International review of psychiatry.

[12]  C. O. Doudney,et al.  Acriflavine modification of nucleic acid formation, mutation induction and survival in ultraviolet light exposed bacteria. , 1964, Biochemical and biophysical research communications.

[13]  C. J. Bond.  ACRIFLAVINE PASTE AS A DRESSING FOR INFECTED WOUNDS , 1917, British medical journal.